Structures, Recruitment and Regulation of Key Components in DNA Damage Response
In plain English
AI plain-English summaryEvery human cell repairs thousands of DNA breaks each day, but when a double-strand break—the most dangerous type—goes unfixed, it can trigger cancer or accelerate aging. This project investigates the molecular machinery that cells use to perform that repair faithfully, focusing on a set of key proteins: the signalling kinases ATR and ATM, the chromatin remodeler INO80, and the tumour suppressors BRCA2, PALB2, and BRCA1. The researchers have already made major advances in understanding these proteins’ structures and core actions under a previous Wellcome Trust award. Now they want to learn how these components are recruited to damage sites and how their activity is regulated. This is fundamental science—there is no immediate clinical application. But the knowledge could eventually explain why certain mutations in BRCA1 or BRCA2 lead to breast and ovarian cancers, and it may suggest new targets for drugs that make cancer cells more vulnerable to DNA-damaging treatments. Similar fundamental work on DNA repair pathways has already underpinned the development of PARP inhibitors, a class of cancer drugs now in routine use.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know